Schedule 13G ownership disclosure
ASTRIA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 04635X102
Event date: 2025-10-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Fairmount Funds Management LLC
Shares: 2,377,049.00 · Class: 4.0%
- Fairmount Healthcare Fund II GP LLC
Shares: 2,377,049.00 · Class: 4.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-099565
- Form type
- SCHEDULE 13G/A
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Oct 15, 2025
- Reporting period
- Oct 14, 2025
- Description
- Schedule 13G beneficial ownership